Skip to content

Docteur WILLAME

Active Private limited companyfounded 2015active for 11 yearsRue d'Avondance 17, 7100 La LouvièreKBO/BCE: BE 0598.884.631

Lifetime

11 annual accounts with figures on one time axis
peak of €112,720 in 2019
€153▼ 97.6%
peak of €65,432 in 2019
€884▼ 81.7%
peak of €325,383 in 2025
€325,383▲ 0.3%
€9,184▼ 57.2%
Board1 name since 2015
1 director
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Gross margin from €6,417 to €153Result from €4,827 to €884Debts from €21,440 to €9,184Investments €1,904

Key points

from the 2025 annual accounts

Equity

€325,383 ▲ 0.3%

Docteur WILLAME has made a profit in every financial year since 2015.

Turnover

≈ €940 estimated

The micro format states no turnover.

Investments

€1,904 2.2 times depreciation
2021202220232025

Green is investment, beige is depreciation.

Liquidity

36.18 was 16.08 in 2024

Short-term debts fell from €21,440 to €9,184.

Filings

11 annual accounts since 2015
AprilJune31 JulyOctober201520202025

Ten of the last ten came late. The 2019 accounts came in latest, 61 days after the end of the period.

Position in the sector

€884

Lower net result than 90% of companies in human health. Sector median €59,553 · 21,334 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 10,916 companies had the same profile as Docteur WILLAME has now. Each dot stands for 28 companies, two years later.

95.1%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 10,916 companies, not a prediction for Docteur WILLAME. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • all the sharesdeed of 25-02-2015
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0598884631
resigns as manager reappointed as director · General meeting of 21-11-2023 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares · appointed as sole manager · Registered office clause: rue d'Avondance 17, 7100 La Louvière (Haine-Saint-Paul) · published on 25-02-2015 · Gazette deed
All 22 events

Comparable companies

same main activity, similar in size and age
Company
Docteur WILLAME La Louvière €334,567 €153 97.3% -
DR. KETELS VEERLE - NEUROLOOG Lokeren €360,430 -€51,265 74.3% -
Goe Gezien Dilbeek €301,250 -€40,504 51.6% -
CABINET DE CHIRURGIE CARDIOVASCULAIRE DU DOCTEUR JEAN-OLIVIER DEFRAIGNE Nandrin €368,012 -€37,560 98.9% 0
DR. JEAN-HENRI DELANNOY, UROLOOG Hoeilaart €432,999 -€12,267 98.7% -
Dokter Marleen Dubin Hasselt €367,155 -€8,796 88.9% -
Société Médicale MD-NCRX Esneux €378,346 -€51,545 82.9% -

These companies have the same main activity as Docteur WILLAME: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €301,000 and €433,000, founded between 2009 and 2018.

Official details

Source: KBO
Status
Active since 23-02-2015Normal situation
Activity
Specialist medical practiceNACE 86220
Financial year end
31 December
Peppol
Reachable since 06-01-2026
Company details

Annual accounts 2025

€334,567▼ 3.3%
Filing
Filed on 28-08-2026
Financials

Insights on Docteur WILLAME

Docteur WILLAME files the micro format. That format states no turnover. The gross margin fell from €104,049 in 2015 to €153 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Docteur WILLAME

What is the company number of Docteur WILLAME?
The company number of Docteur WILLAME is 0598.884.631. The VAT number is the same number with BE in front: BE 0598.884.631.
Where is Docteur WILLAME based?
The registered office is at Rue d'Avondance 17, 7100 La Louvière.Company details
What does Docteur WILLAME do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Docteur WILLAME?
Docteur WILLAME is a private limited company (BV).
When was Docteur WILLAME founded?
Docteur WILLAME was founded on 23-02-2015.
Is Docteur WILLAME still active?
Yes, Docteur WILLAME is an active enterprise in the KBO register.
What is the turnover of Docteur WILLAME?
The turnover in financial year 2025 is ≈ €940. This figure is estimated from the gross margin of €153 and 52 comparable companies (NACE 86). It probably lies between €650 and €1,700. It is a rough estimate.Financials
Is Docteur WILLAME profitable?
In financial year 2025, Docteur WILLAME made a profit of €884.
Where can I find the annual accounts of Docteur WILLAME?
Docteur WILLAME filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Docteur WILLAME due?
Docteur WILLAME must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.